The purpose of the study is to emphasize the etiopathogenetic role of IDH mutation and its potential therapeutic role simultaneously for Ollier Disease, brain gliomas, and acute myeloid leukemia. The gene discussed is IDH1; the disease is acute myeloid leukemia.